Newcastle Disease Vaccine Industry Research Report 2024
Summary
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, the global Newcastle Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The report will help the Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Newcastle Disease Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, the global Newcastle Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The report will help the Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Newcastle Disease Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Newcastle Disease Vaccine Sales (2019-2030)
2.2.3 Global Newcastle Disease Vaccine Market Average Price (2019-2030)
2.3 Newcastle Disease Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Live Vaccines
2.3.3 Killed Vaccines
2.4 Newcastle Disease Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Chicken
2.4.3 Duck & Goose
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Newcastle Disease Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Newcastle Disease Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Newcastle Disease Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application
3.8 Global Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
3.9 Global Newcastle Disease Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merial
4.1.1 Merial Company Information
4.1.2 Merial Business Overview
4.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merial Newcastle Disease Vaccine Product Portfolio
4.1.5 Merial Recent Developments
4.2 CEVA
4.2.1 CEVA Company Information
4.2.2 CEVA Business Overview
4.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
4.2.5 CEVA Recent Developments
4.3 QYH Biotech
4.3.1 QYH Biotech Company Information
4.3.2 QYH Biotech Business Overview
4.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
4.3.5 QYH Biotech Recent Developments
4.4 Ringpu Biology
4.4.1 Ringpu Biology Company Information
4.4.2 Ringpu Biology Business Overview
4.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
4.4.5 Ringpu Biology Recent Developments
4.5 Yebio
4.5.1 Yebio Company Information
4.5.2 Yebio Business Overview
4.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
4.5.5 Yebio Recent Developments
4.6 Harbin Veterinary Research Institute
4.6.1 Harbin Veterinary Research Institute Company Information
4.6.2 Harbin Veterinary Research Institute Business Overview
4.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
4.6.5 Harbin Veterinary Research Institute Recent Developments
4.7 Merck Animal Health
4.7.1 Merck Animal Health Company Information
4.7.2 Merck Animal Health Business Overview
4.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
4.7.5 Merck Animal Health Recent Developments
4.8 DHN
4.8.1 DHN Company Information
4.8.2 DHN Business Overview
4.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 DHN Newcastle Disease Vaccine Product Portfolio
4.8.5 DHN Recent Developments
4.9 Zoetis
4.9.1 Zoetis Company Information
4.9.2 Zoetis Business Overview
4.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
4.9.5 Zoetis Recent Developments
4.10 ChengDu Tecbond
4.10.1 ChengDu Tecbond Company Information
4.10.2 ChengDu Tecbond Business Overview
4.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
4.10.5 ChengDu Tecbond Recent Developments
4.11 Elanco (Lohmann)
4.11.1 Elanco (Lohmann) Company Information
4.11.2 Elanco (Lohmann) Business Overview
4.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
4.11.5 Elanco (Lohmann) Recent Developments
4.12 FATRO
4.12.1 FATRO Company Information
4.12.2 FATRO Business Overview
4.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
4.12.5 FATRO Recent Developments
4.13 CAVAC
4.13.1 CAVAC Company Information
4.13.2 CAVAC Business Overview
4.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
4.13.5 CAVAC Recent Developments
4.14 Vaksindo
4.14.1 Vaksindo Company Information
4.14.2 Vaksindo Business Overview
4.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
4.14.5 Vaksindo Recent Developments
5 GLOBAL NEWCASTLE DISEASE VACCINE MARKET SCENARIO BY REGION
5.1 Global Newcastle Disease Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Newcastle Disease Vaccine Sales by Region: 2019-2030
5.2.1 Global Newcastle Disease Vaccine Sales by Region: 2019-2024
5.2.2 Global Newcastle Disease Vaccine Sales by Region: 2025-2030
5.3 Global Newcastle Disease Vaccine Revenue by Region: 2019-2030
5.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2019-2024
5.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2025-2030
5.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
5.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Newcastle Disease Vaccine Sales by Country (2019-2030)
5.4.3 North America Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
5.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2030)
5.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
5.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030)
6.1.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Newcastle Disease Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030)
7.1.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030)
7.2.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Newcastle Disease Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Newcastle Disease Vaccine Value Chain Analysis
8.1.1 Newcastle Disease Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Newcastle Disease Vaccine Production Mode & Process
8.2 Newcastle Disease Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Newcastle Disease Vaccine Distributors
8.2.3 Newcastle Disease Vaccine Customers
9 GLOBAL NEWCASTLE DISEASE VACCINE ANALYZING MARKET DYNAMICS
9.1 Newcastle Disease Vaccine Industry Trends
9.2 Newcastle Disease Vaccine Industry Drivers
9.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
9.4 Newcastle Disease Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Newcastle Disease Vaccine Sales (2019-2030)
2.2.3 Global Newcastle Disease Vaccine Market Average Price (2019-2030)
2.3 Newcastle Disease Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Live Vaccines
2.3.3 Killed Vaccines
2.4 Newcastle Disease Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Chicken
2.4.3 Duck & Goose
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Newcastle Disease Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Newcastle Disease Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Newcastle Disease Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application
3.8 Global Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
3.9 Global Newcastle Disease Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merial
4.1.1 Merial Company Information
4.1.2 Merial Business Overview
4.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merial Newcastle Disease Vaccine Product Portfolio
4.1.5 Merial Recent Developments
4.2 CEVA
4.2.1 CEVA Company Information
4.2.2 CEVA Business Overview
4.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
4.2.5 CEVA Recent Developments
4.3 QYH Biotech
4.3.1 QYH Biotech Company Information
4.3.2 QYH Biotech Business Overview
4.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
4.3.5 QYH Biotech Recent Developments
4.4 Ringpu Biology
4.4.1 Ringpu Biology Company Information
4.4.2 Ringpu Biology Business Overview
4.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
4.4.5 Ringpu Biology Recent Developments
4.5 Yebio
4.5.1 Yebio Company Information
4.5.2 Yebio Business Overview
4.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
4.5.5 Yebio Recent Developments
4.6 Harbin Veterinary Research Institute
4.6.1 Harbin Veterinary Research Institute Company Information
4.6.2 Harbin Veterinary Research Institute Business Overview
4.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
4.6.5 Harbin Veterinary Research Institute Recent Developments
4.7 Merck Animal Health
4.7.1 Merck Animal Health Company Information
4.7.2 Merck Animal Health Business Overview
4.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
4.7.5 Merck Animal Health Recent Developments
4.8 DHN
4.8.1 DHN Company Information
4.8.2 DHN Business Overview
4.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 DHN Newcastle Disease Vaccine Product Portfolio
4.8.5 DHN Recent Developments
4.9 Zoetis
4.9.1 Zoetis Company Information
4.9.2 Zoetis Business Overview
4.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
4.9.5 Zoetis Recent Developments
4.10 ChengDu Tecbond
4.10.1 ChengDu Tecbond Company Information
4.10.2 ChengDu Tecbond Business Overview
4.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
4.10.5 ChengDu Tecbond Recent Developments
4.11 Elanco (Lohmann)
4.11.1 Elanco (Lohmann) Company Information
4.11.2 Elanco (Lohmann) Business Overview
4.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
4.11.5 Elanco (Lohmann) Recent Developments
4.12 FATRO
4.12.1 FATRO Company Information
4.12.2 FATRO Business Overview
4.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
4.12.5 FATRO Recent Developments
4.13 CAVAC
4.13.1 CAVAC Company Information
4.13.2 CAVAC Business Overview
4.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
4.13.5 CAVAC Recent Developments
4.14 Vaksindo
4.14.1 Vaksindo Company Information
4.14.2 Vaksindo Business Overview
4.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
4.14.5 Vaksindo Recent Developments
5 GLOBAL NEWCASTLE DISEASE VACCINE MARKET SCENARIO BY REGION
5.1 Global Newcastle Disease Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Newcastle Disease Vaccine Sales by Region: 2019-2030
5.2.1 Global Newcastle Disease Vaccine Sales by Region: 2019-2024
5.2.2 Global Newcastle Disease Vaccine Sales by Region: 2025-2030
5.3 Global Newcastle Disease Vaccine Revenue by Region: 2019-2030
5.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2019-2024
5.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2025-2030
5.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
5.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Newcastle Disease Vaccine Sales by Country (2019-2030)
5.4.3 North America Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
5.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2030)
5.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
5.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030)
6.1.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Newcastle Disease Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030)
7.1.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030)
7.2.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Newcastle Disease Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Newcastle Disease Vaccine Value Chain Analysis
8.1.1 Newcastle Disease Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Newcastle Disease Vaccine Production Mode & Process
8.2 Newcastle Disease Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Newcastle Disease Vaccine Distributors
8.2.3 Newcastle Disease Vaccine Customers
9 GLOBAL NEWCASTLE DISEASE VACCINE ANALYZING MARKET DYNAMICS
9.1 Newcastle Disease Vaccine Industry Trends
9.2 Newcastle Disease Vaccine Industry Drivers
9.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
9.4 Newcastle Disease Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Newcastle Disease Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Newcastle Disease Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Newcastle Disease Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merial Company Information
Table 17. Merial Business Overview
Table 18. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Merial Newcastle Disease Vaccine Product Portfolio
Table 20. Merial Recent Developments
Table 21. CEVA Company Information
Table 22. CEVA Business Overview
Table 23. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. CEVA Newcastle Disease Vaccine Product Portfolio
Table 25. CEVA Recent Developments
Table 26. QYH Biotech Company Information
Table 27. QYH Biotech Business Overview
Table 28. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 30. QYH Biotech Recent Developments
Table 31. Ringpu Biology Company Information
Table 32. Ringpu Biology Business Overview
Table 33. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 35. Ringpu Biology Recent Developments
Table 36. Yebio Company Information
Table 37. Yebio Business Overview
Table 38. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Yebio Newcastle Disease Vaccine Product Portfolio
Table 40. Yebio Recent Developments
Table 41. Harbin Veterinary Research Institute Company Information
Table 42. Harbin Veterinary Research Institute Business Overview
Table 43. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 45. Harbin Veterinary Research Institute Recent Developments
Table 46. Merck Animal Health Company Information
Table 47. Merck Animal Health Business Overview
Table 48. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 50. Merck Animal Health Recent Developments
Table 51. DHN Company Information
Table 52. DHN Business Overview
Table 53. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. DHN Newcastle Disease Vaccine Product Portfolio
Table 55. DHN Recent Developments
Table 56. Zoetis Company Information
Table 57. Zoetis Business Overview
Table 58. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 60. Zoetis Recent Developments
Table 61. ChengDu Tecbond Company Information
Table 62. ChengDu Tecbond Business Overview
Table 63. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 64. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 65. ChengDu Tecbond Recent Developments
Table 66. Elanco (Lohmann) Company Information
Table 67. Elanco (Lohmann) Business Overview
Table 68. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 69. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 70. Elanco (Lohmann) Recent Developments
Table 71. FATRO Company Information
Table 72. FATRO Business Overview
Table 73. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 74. FATRO Newcastle Disease Vaccine Product Portfolio
Table 75. FATRO Recent Developments
Table 76. CAVAC Company Information
Table 77. CAVAC Business Overview
Table 78. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 79. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 80. CAVAC Recent Developments
Table 81. Vaksindo Company Information
Table 82. Vaksindo Business Overview
Table 83. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 84. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 85. Vaksindo Recent Developments
Table 86. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Newcastle Disease Vaccine Sales by Region (2018-2023) & (M Doses)
Table 88. Global Newcastle Disease Vaccine Sales Market Share by Region (2018-2023)
Table 89. Global Newcastle Disease Vaccine Sales by Region (2024-2029) & (M Doses)
Table 90. Global Newcastle Disease Vaccine Sales Market Share by Region (2024-2029)
Table 91. Global Newcastle Disease Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Newcastle Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 93. Global Newcastle Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Newcastle Disease Vaccine Revenue Market Share by Region (2024-2029)
Table 95. North America Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 97. North America Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 98. North America Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 102. Europe Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 103. Europe Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 107. Asia Pacific Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 108. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 112. Latin America Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 113. Latin America Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 117. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 118. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 121. Global Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 122. Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2023)
Table 123. Global Newcastle Disease Vaccine Sales Market Share by Type (2024-2029)
Table 124. Global Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 125. Global Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 126. Global Newcastle Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 127. Global Newcastle Disease Vaccine Revenue Market Share by Type (2024-2029)
Table 128. Global Newcastle Disease Vaccine Price by Type (2018-2023) & (USD/K Doses)
Table 129. Global Newcastle Disease Vaccine Price by Type (2024-2029) & (USD/K Doses)
Table 130. Global Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 131. Global Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 132. Global Newcastle Disease Vaccine Sales Market Share by Application (2018-2023)
Table 133. Global Newcastle Disease Vaccine Sales Market Share by Application (2024-2029)
Table 134. Global Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Newcastle Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 137. Global Newcastle Disease Vaccine Revenue Market Share by Application (2024-2029)
Table 138. Global Newcastle Disease Vaccine Price by Application (2018-2023) & (USD/K Doses)
Table 139. Global Newcastle Disease Vaccine Price by Application (2024-2029) & (USD/K Doses)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Newcastle Disease Vaccine Distributors List
Table 143. Newcastle Disease Vaccine Customers List
Table 144. Newcastle Disease Vaccine Industry Trends
Table 145. Newcastle Disease Vaccine Industry Drivers
Table 146. Newcastle Disease Vaccine Industry Restraints
Table 147. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Newcastle Disease Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Newcastle Disease Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Newcastle Disease Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merial Company Information
Table 17. Merial Business Overview
Table 18. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Merial Newcastle Disease Vaccine Product Portfolio
Table 20. Merial Recent Developments
Table 21. CEVA Company Information
Table 22. CEVA Business Overview
Table 23. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. CEVA Newcastle Disease Vaccine Product Portfolio
Table 25. CEVA Recent Developments
Table 26. QYH Biotech Company Information
Table 27. QYH Biotech Business Overview
Table 28. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 30. QYH Biotech Recent Developments
Table 31. Ringpu Biology Company Information
Table 32. Ringpu Biology Business Overview
Table 33. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 35. Ringpu Biology Recent Developments
Table 36. Yebio Company Information
Table 37. Yebio Business Overview
Table 38. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Yebio Newcastle Disease Vaccine Product Portfolio
Table 40. Yebio Recent Developments
Table 41. Harbin Veterinary Research Institute Company Information
Table 42. Harbin Veterinary Research Institute Business Overview
Table 43. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 45. Harbin Veterinary Research Institute Recent Developments
Table 46. Merck Animal Health Company Information
Table 47. Merck Animal Health Business Overview
Table 48. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 50. Merck Animal Health Recent Developments
Table 51. DHN Company Information
Table 52. DHN Business Overview
Table 53. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. DHN Newcastle Disease Vaccine Product Portfolio
Table 55. DHN Recent Developments
Table 56. Zoetis Company Information
Table 57. Zoetis Business Overview
Table 58. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 60. Zoetis Recent Developments
Table 61. ChengDu Tecbond Company Information
Table 62. ChengDu Tecbond Business Overview
Table 63. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 64. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 65. ChengDu Tecbond Recent Developments
Table 66. Elanco (Lohmann) Company Information
Table 67. Elanco (Lohmann) Business Overview
Table 68. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 69. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 70. Elanco (Lohmann) Recent Developments
Table 71. FATRO Company Information
Table 72. FATRO Business Overview
Table 73. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 74. FATRO Newcastle Disease Vaccine Product Portfolio
Table 75. FATRO Recent Developments
Table 76. CAVAC Company Information
Table 77. CAVAC Business Overview
Table 78. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 79. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 80. CAVAC Recent Developments
Table 81. Vaksindo Company Information
Table 82. Vaksindo Business Overview
Table 83. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 84. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 85. Vaksindo Recent Developments
Table 86. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Newcastle Disease Vaccine Sales by Region (2018-2023) & (M Doses)
Table 88. Global Newcastle Disease Vaccine Sales Market Share by Region (2018-2023)
Table 89. Global Newcastle Disease Vaccine Sales by Region (2024-2029) & (M Doses)
Table 90. Global Newcastle Disease Vaccine Sales Market Share by Region (2024-2029)
Table 91. Global Newcastle Disease Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Newcastle Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 93. Global Newcastle Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Newcastle Disease Vaccine Revenue Market Share by Region (2024-2029)
Table 95. North America Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 97. North America Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 98. North America Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 102. Europe Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 103. Europe Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 107. Asia Pacific Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 108. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 112. Latin America Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 113. Latin America Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 117. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 118. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 121. Global Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 122. Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2023)
Table 123. Global Newcastle Disease Vaccine Sales Market Share by Type (2024-2029)
Table 124. Global Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 125. Global Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 126. Global Newcastle Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 127. Global Newcastle Disease Vaccine Revenue Market Share by Type (2024-2029)
Table 128. Global Newcastle Disease Vaccine Price by Type (2018-2023) & (USD/K Doses)
Table 129. Global Newcastle Disease Vaccine Price by Type (2024-2029) & (USD/K Doses)
Table 130. Global Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 131. Global Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 132. Global Newcastle Disease Vaccine Sales Market Share by Application (2018-2023)
Table 133. Global Newcastle Disease Vaccine Sales Market Share by Application (2024-2029)
Table 134. Global Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Newcastle Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 137. Global Newcastle Disease Vaccine Revenue Market Share by Application (2024-2029)
Table 138. Global Newcastle Disease Vaccine Price by Application (2018-2023) & (USD/K Doses)
Table 139. Global Newcastle Disease Vaccine Price by Application (2024-2029) & (USD/K Doses)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Newcastle Disease Vaccine Distributors List
Table 143. Newcastle Disease Vaccine Customers List
Table 144. Newcastle Disease Vaccine Industry Trends
Table 145. Newcastle Disease Vaccine Industry Drivers
Table 146. Newcastle Disease Vaccine Industry Restraints
Table 147. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Newcastle Disease VaccineProduct Picture
Figure 5. Global Newcastle Disease Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Newcastle Disease Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Newcastle Disease Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2018-2029)
Figure 9. Live Vaccines Product Picture
Figure 10. Killed Vaccines Product Picture
Figure 11. Chicken Product Picture
Figure 12. Duck & Goose Product Picture
Figure 13. Other Product Picture
Figure 14. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Newcastle Disease Vaccine Sales by Region in 2022
Figure 21. Global Newcastle Disease Vaccine Revenue by Region in 2022
Figure 22. North America Newcastle Disease Vaccine Market Size by Country in 2022
Figure 23. North America Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 24. North America Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Newcastle Disease Vaccine Market Size by Country in 2022
Figure 28. Europe Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 29. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Newcastle Disease Vaccine Market Size by Country in 2022
Figure 36. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 38. China Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Newcastle Disease Vaccine Market Size by Country in 2022
Figure 48. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Newcastle Disease Vaccine Market Size by Country in 2022
Figure 54. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Global Newcastle Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2018-2029)
Figure 62. Global Newcastle Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Global Newcastle Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2018-2029)
Figure 65. Newcastle Disease Vaccine Value Chain
Figure 66. Newcastle Disease Vaccine Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Newcastle Disease Vaccine Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Newcastle Disease VaccineProduct Picture
Figure 5. Global Newcastle Disease Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Newcastle Disease Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Newcastle Disease Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2018-2029)
Figure 9. Live Vaccines Product Picture
Figure 10. Killed Vaccines Product Picture
Figure 11. Chicken Product Picture
Figure 12. Duck & Goose Product Picture
Figure 13. Other Product Picture
Figure 14. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Newcastle Disease Vaccine Sales by Region in 2022
Figure 21. Global Newcastle Disease Vaccine Revenue by Region in 2022
Figure 22. North America Newcastle Disease Vaccine Market Size by Country in 2022
Figure 23. North America Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 24. North America Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Newcastle Disease Vaccine Market Size by Country in 2022
Figure 28. Europe Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 29. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Newcastle Disease Vaccine Market Size by Country in 2022
Figure 36. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 38. China Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Newcastle Disease Vaccine Market Size by Country in 2022
Figure 48. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Newcastle Disease Vaccine Market Size by Country in 2022
Figure 54. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Newcastle Disease Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Global Newcastle Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2018-2029)
Figure 62. Global Newcastle Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Global Newcastle Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2018-2029)
Figure 65. Newcastle Disease Vaccine Value Chain
Figure 66. Newcastle Disease Vaccine Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Newcastle Disease Vaccine Industry Opportunities and Challenges
